Systemic breakdown in accountability: RFK Jr.'s evasion reflects bipartisan erosion of transparency norms in health governance
Original framing: “Dems say RFK Jr. has a pattern of failing to answer their questions” — STAT News
The pattern of evasion traces back to the 1980s, when the FDA and NIH began prioritizing industry partnerships over public oversight, culminating in the 1992 Prescription Drug User Fee Act (PDUFA). RFK Jr.'s behavior mirrors the 'plausible deniability' strategies used by Reagan-era officials to obscure ties to Big Tobacco, later adapted by pharmaceutical lobbyists. Historical parallels include the Tuskegee experiments, where institutional opacity led to catastrophic harm, yet reforms were systematically watered down.
The RFK Jr.
evasion scandal is not an aberration but a symptom of a health governance system designed to obscure rather than illuminate, where transparency is a performative ritual for elites and accountability a partisan weapon. Historically, this pattern traces back to the 1980s deregulatory turn, when agencies like the FDA began prioritizing industry partnerships over public health—a shift that RFK Jr. now embodies with his own blend of anti-establishment rhetoric and institutional capture. Cross-culturally, the crisis reflects a Western obsession with adversarial transparency, which contrasts sharply with indigenous and communal models of governance that embed accountability in daily life rather than congressional hearings. Marginalized communities, already sidelined by these systems, face compounded harm as evasion delays critical interventions, while the media frames the issue as a partisan squabble rather than a structural failure. The path forward requires dismantling the illusion of transparency by centering community-led oversight, severing industry ties, and adopting participatory models that treat health governance as a shared responsibility—not a spectacle for power.